92.03
Healthequity Inc stock is traded at $92.03, with a volume of 550.68K.
It is down -0.52% in the last 24 hours and down -4.14% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$92.51
Open:
$93.23
24h Volume:
550.68K
Relative Volume:
0.73
Market Cap:
$7.61B
Revenue:
$1.34B
Net Income/Loss:
$230.70M
P/E Ratio:
34.47
EPS:
2.6695
Net Cash Flow:
$440.96M
1W Performance:
-0.63%
1M Performance:
-4.14%
6M Performance:
+8.87%
1Y Performance:
+1.09%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, BTSG, TEM, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
92.03 | 7.61B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
VEEV
Veeva Systems Inc
|
310.36 | 50.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
60.87 | 12.04B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
64.72 | 11.75B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HNGE
Hinge Health Inc
|
99.16 | 8.00B | 646.34M | -512.40M | 202.76M | -6.6871 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Zacks Investment Research
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
HealthEquity, Inc. (HQY) Stock Price, News, Quote & History - Yahoo! Finance Canada
HealthEquity Terminates Chief Commercial Officer Michael Fiore - Yahoo Finance
How Healthequity Inc. (HQY) Affects Rotational Strategy Timing - Stock Traders Daily
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo! Finance Canada
HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen - MarketBeat
One investment adviser reports a passive stake of 7.01 million shares in HealthEquity (HQY). - Stock Titan
Form 4 Healthequity Inc For: 8 October By Investing.com - Investing.com Nigeria
Tax withholding requires Delano Ladd’s planned $98.4K share sale at HealthEquity (HQY). - Stock Titan
Former executive Fiore holds 50,212 direct shares in HealthEquity (HQY) after disposing of 2,032 shares. - Stock Titan
Tax withholding requires a proposed 2,032-share sale at HealthEquity (HQY). - Stock Titan
1,095 shares were delivered or withheld for exercise price or tax liability at HealthEquity (HQY). - Stock Titan
To cover taxes, HealthEquity (HQY) officer Stephen Neeleman proposes selling 1,095 shares. - Stock Titan
After delivering or withholding 662 shares, HealthEquity (HQY) officer holds 39,231 directly. - Stock Titan
A proposed 662-share sale by a HealthEquity (HQY) officer is mandated to cover tax withholding. - Stock Titan
HealthEquity (HQY) CFO shares were delivered or withheld for exercise-price or tax payment: 2,822 shares. - Stock Titan
A required tax-cover sale, not a discretionary trade: HealthEquity (HQY) officer lists 2,822 shares. - Stock Titan
1,230 shares were delivered or withheld for HealthEquity (HQY) CEO Scott Cutler. - Stock Titan
HealthEquity (MIL:1HQY) Other Long Term Assets : €67.83 Mil (As of Jul. 2026) - GuruFocus
HealthEquity (NASDAQ:HQY) Share Price Breaks Below 50-Day Moving AverageWhat's Next? - MarketBeat
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Healthequity Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
HealthEquity (MIL:1HQY) Cyclically Adjusted Price-to-FCF : (As of Oct. 05, 2026) - GuruFocus
HealthEquity (MIL:1HQY) 10-Year ROIIC % : 8.03% (As of Jan. 2026) - GuruFocus
HealthEquity (MIL:1HQY) Other Gross PPE : €42.13 Mil (As of Jul. 2026) - GuruFocus
HealthEquity (MIL:1HQY) EBIT per Share : €3.60 (TTM As of Jul. 2026) - GuruFocus
MIL:1HQY Dividend: Does HealthEquity Inc Pay a Dividend? - GuruFocus
Who's Buying or Selling HealthEquity Inc (MIL:1HQY) Stock Today? - GuruFocus
MIL:1HQY 3-Year EBITDA Growth Rate: 40.20% — 10% Above Med - GuruFocus
HealthEquity Inc Stock Warning Signs | MIL:1HQY - GuruFocus
HealthEquity Inc (MIL:1HQY) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
HealthEquity: AI Cash Fears Create A 'Buy' Opportunity (NASDAQ:HQY) - Seeking Alpha
(HQY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
A director reports 2,033 shares at HealthEquity (HQY), with delivery upon June 2027 vesting. - Stock Titan
HealthEquity adds Moody’s CFO to board of directors - Investing.com
HealthEquity adds Moody’s CFO to board of directors By Investing.com - Investing.com Nigeria
Noémie Heuland joins HealthEquity board as CFO of Moody’s, to serve on Audit & Cybersecurity committees - TradingView
HealthEquity Appoints Moody’s CFO Noémie Heul - moomoo.com
HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors - Yahoo Finance
HealthEquity’s board now has 11 directors, nine independent, after Moody’s finance chief joined. - Stock Titan
HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors - GlobeNewswire
HQY5271388 Bond Profile: Coupon and Redemption - TradingView
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Healthequity Inc Stock (HQY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| James M. Lucania | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
2,822 |
257,240 |
0 |
| Michael Gathright | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
662 |
60,345 |
0 |
| Stephen Neeleman | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
1,095 |
99,815 |
0 |
| Michael Henry Fiore | Former EVP, CCO |
Oct 06 '26 |
Proposed Sale |
91.16 |
2,032 |
185,228 |
0 |
| Scott Cutler | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
1,230 |
112,121 |
0 |
| ADRIAN DILLON | Director |
Aug 25 '26 |
Proposed Sale |
105.40 |
7,632 |
804,413 |
0 |
| DILLON ADRIAN T | Director |
Aug 25 '26 |
Sale |
104.61 |
7,632 |
798,373 |
62,395 |
| DILLON ADRIAN T | Director |
Aug 25 '26 |
Option Exercise |
32.50 |
7,632 |
248,040 |
70,027 |
| Fiore Michael Henry | EVP, CHIEF COMMERCIAL OFFICER |
Jul 10 '26 |
Sale |
95.00 |
2,354 |
223,630 |
52,244 |
| MICHAEL FIORE | Officer |
Jul 10 '26 |
Proposed Sale |
94.81 |
2,354 |
223,183 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):